REG - RTW Venture Fund Ltd - Net Asset Value(s)

RTW Biotech OpportunitiesAnnouncement

13/11/2020 07:00

RNS Number : 1984F
  
RTW Venture Fund Limited
  
13 November 2020
  
 

LEI: 549300Q7EXQQH6KF7Z84
13 November 2020
RTW Venture Fund Limited
Net Asset Value
RTW Venture Fund Limited (the "Company") announces that the unaudited net asset value attributable to the ordinary shares of the Company at the close of business on 30 October 2020 (the "NAV") was US$274.4 million, or US$1.46 per ordinary share.
As at 30 October 2020, 22.8 per cent. of the total NAV was invested in privately-held core portfolio companies.
For Further Information
RTW Investments, LP                                    +1 (646) 343 9280

Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Business Development Associate
 
Ocorian (Company Secretary)                       +44 (0)1481 742 642

Kevin Smith
 
J.P. Morgan Cazenove                                   +44 (0)20 7742 4000
William Simmonds
James Bouverat (Sales)
 
Barclays                                                       +44 (0)20 7623 2323
Tom Swerling
Andrew Tusa
 
Note:




1.


The NAV is determined by the Company's investment manager, RTW Investments, LP, in accordance with the Company's accounting policies.  Investments by the Company in privately-held companies ("Private Portfolio Companies") have been valued at fair market value, taking into account the valuation prepared by Alvarez & Marsal Valuation Services LLC and the nature, facts and circumstances of the Private Portfolio Companies. Investments by the Company in companies listed on a public stock exchange (the "Public Portfolio Companies") have each been valued by reference to their market capitalisation as at close of business on 30 October 2020. The Company applies a valuation discount to its investments in Public Portfolio Companies that are subject to post-IPO lock-up provisions.




About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. 
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NAVGPGPAGUPUPUP